CD8A and neoplasm: Mice treated with the Ace-Resi group demonstrated increased frequencies and counts of CD8+ T cells (Fig. 2F, Supp Fig. 4G), interferon gamma (IFNγ+) CD8+ T cells (Fig. 2G, Supp Fig. 4H), and polyfunctional IFNγ+ GzmB+ CD8+ T cells (Fig. 2H, Supp Fig. 4I) compared to naïve tumor-bearing mice and healthy (no tumor) controls.